Manufacturer confirms discontinuation of type 2 diabetes mellitus ...
Oct 21, 2024 · Novo Nordisk has confirmed that its Victoza (liraglutide) 6mg/mL pre-filled injection pens have been discontinued.
Novo Nordisk discontinues type 2 diabetes treatment Victoza
Oct 22, 2024 · Victoza (liraglutide) pre-filled injection pens, used in the treatment of type 2 diabetes mellitus, have been out of stock in the UK since August 2023.
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza
Dec 23, 2024 · The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the …
Ozempic shortage makes Novo Nordisk reduce supply of Victoza …
Nov 22, 2023 · Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing …
There’s still no generic Ozempic, but a lower-priced daily ... - CNN
Dec 23, 2024 · Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish …
Novo asks FDA to restrict Victoza compounding amid GLP-1 …
Jan 3, 2025 · In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, …
Novo Launches Citizen Petition to Block Compounded Victoza
Jan 6, 2025 · Novo Nordisk last month filed a Citizen Petition with the FDA asking the federal agency to exclude its type 2 diabetes injection Victoza (liraglutide) from a proposed list of …
Novo Nordisk seeks to block compounded Victoza (NVO:NYSE)
Jan 3, 2025 · Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded.
Victoza patent dispute settled between Novo Nordisk and Teva
Mar 19, 2019 · Danish pharmaceutical company Novo Nordisk has reached an agreement with Teva Pharmaceuticals USA to settle the patent dispute in the US over its type 2 diabetes drug …
Teva launches generic version of Novo Nordisk's diabetes drug Victoza …
Jun 24, 2024 · Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's Victoza to treat patients with type 2 diabetes, making it the first generic GLP-1 drug …